Loading... Please wait... Loading... Please wait...
ESTIMATED
05/15/2024
05/15/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2024 | 0 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2024 | 0 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2025 | 0 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 0 | -$0.05 | -$0.05 | -$0.05 |
Renalytix Plc last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0.01. The company had revenue of 535,000 for the quarter and had revenue of 3.40 M for the year. Renalytix Plc has generated $-1 earnings per share over the last year ($-1.12 diluted earnings per share) and currently has a price-to-earnings ratio of -0.3. Renalytix Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 26th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/15/2024 | Q3 2024 | -$0.07 | -$0.16 | -0.09 | $1.09 M | $535,000 | 02/14/2024 | Q2 2024 | -$0.17 | $763,500 | $709,000 | 09/29/2023 | Q1 2024 | -$0.21 | $459,000 | 06/09/2023 | Q4 2023 | -$0.13 | -$0.24 | -0.11 | $518,000 | 03/30/2023 | Q3 2023 | -$0.15 | -$0.28 | -0.13 | $1.48 M | $724,000 | 12/31/2022 | Q2 2023 | -$0.32 | $1.28 M | $1.19 M | 11/22/2022 | Q1 2023 | -$0.32 | $969,000 | 06/30/2022 | Q4 2022 | -$0.17 | -$0.46 | -0.29 | $831,000 | 03/31/2022 | Q3 2022 | -$0.17 | -$0.41 | -0.24 | $812,000 | 12/31/2021 | Q2 2022 | -$0.51 | $550,000 | $845,000 | 09/30/2021 | Q1 2022 | -$0.28 | $2.30 M | $482,000 | 10/21/2021 | Q4 2021 | -$0.23 | $472,000 | 03/31/2021 | Q3 2021 | -$0.24 | $619,000 | 12/31/2020 | Q2 2021 | -$0.25 | $400,000 | 09/30/2020 | Q1 2021 | -$0.21 | $619,000 | 10/27/2020 | Q4 2020 | -$0.09 | $0 | 03/31/2020 | Q3 2020 | -$0.02 | $0 | 12/31/2019 | Q2 2020 | -$0.16 | $0 | 09/30/2019 | Q1 2020 | -$0.05 | $0 | 06/30/2018 | Q4 2018 | -$0.00 | $0 |
|---|
A. Renalytix Plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 26th, 2024 based off last year's report dates.
A. The conference call for Renalytix Plc's latest earnings report can be listened to online.
A. The conference call transcript for Renalytix Plc's latest earnings report can be read online.
A. Renalytix Plc (NASDAQ:RNLX) has a recorded annual revenue of $3.40 M.
A. Renalytix Plc (NASDAQ:RNLX) has a recorded net income of $3.40 M. Renalytix Plc has generated $-1.12 earnings per share over the last four quarters.
A. Renalytix Plc (NASDAQ:RNLX) has a price-to-earnings ratio of -0.3 and price/earnings-to-growth ratio is -0.01.
